Kazia Therapeutics Ltd Share Price

NASDAQ: KZIA

Small Cap

$8.08

+0.09

(+1.13%)

as on September 17, 2025 at 12:48 am IST

$₹

Kazia Therapeutics Ltd Stock Performance

as on September 17, 2025 at 12:48 am IST

Day's Low
Day's High
$7.78
Day's Price Range
$8.28
$8.08
3.71%
Downside
2.48%
Upside
52 Week's Low
52 Week's High
$2.86
52-Week Price Range
$39.05
$8.08
64.60%
Downside
383.29%
Upside

Kazia Therapeutics Ltd share price movements today

Previous Close: $7.99
Open: $7.90
Volume: 245.0K
Day's Low - High: $7.78 - $8.28
52 Week Low - High: $2.86 - $39.05

Kazia Therapeutics Ltd Historical Returns

1 Month Return: -0.56 %
3 Month Return: -14.36 %
1 Year Return: -50.09 %
3 Year Return: -88.83 %
5 Year Return: -97.68 %

Kazia Therapeutics Ltd Stock Fundamentals & Key Indicators

Check Kazia Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.9M

EPS (TTM)

-0.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-27.1M

Revenue (TTM)

2.5M

Profit Margin

0.00%

Return On Equity TTM

33874200.00%

Kazia Therapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kazia Therapeutics Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Kazia Therapeutics Ltd	BUY	$10.9M	-97.68%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Kazia Therapeutics Ltd Stock including INR - Dollar returns

The Kazia Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Kazia Therapeutics Ltd investment value today

Current value as on today

₹55,336

Returns

₹44,664

(-44.66%)

Returns from Kazia Therapeutics Ltd Stock

₹49,532 (-49.53%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Kazia Therapeutics Ltd Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Kazia Therapeutics Ltd. Average target price of $14.2

Kazia Therapeutics Ltd Share Price Target

Get share price movements and forecasts by analysts on Kazia Therapeutics Ltd.

What analysts predicted

43.1%UPSIDE

Target Price

$14.2

Current Price

$8.08

Analyzed by

7 Analysts

Target

$14.20

Kazia Therapeutics Ltd target price $14.2, a slight upside of 43.1% compared to current price of $8.08. According to 7 analysts rating.

Kazia Therapeutics Ltd Stock's Interest Amongst Investors

Search interest for Kazia Therapeutics Ltd Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-23% versus previous 30 day period

Kazia Therapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2021	Sep 2022	Mar 2023	Sep 2023	Dec 2023	Sep 2024
Total Revenue	0	-1	0	0	0	2
Gross Profit	0	-1	0	0	0	2
Operating Income	-13	-11	-5	-10	-8	-19
EBITDA	-12	-11	-4	-9	-7	-18
Interest Expense	-	4	-	-	-	-
Depreciation	-	-	-	-	-	-
Income Before Tax	-13	-11	-3	-7	-8	-18
Income Tax Expense	0	0	0	0	0	0
Net Income	-9	-7	-2	-4	-5	-17
Net Profit Margin	-132018.48%	407.56%	-1237257.55%	-1239487.03%	-176470260.00%	-723.68%

Kazia Therapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Total Revenue	0	3	6	0	0	0	11	0	0	1
Gross Profit	0	3	6	0	0	0	11	0	0	1
Operating Income	-8	-12	-10	-12	-8	-12	-6	-26	-24	-28
EBITDA	-7	-11	-9	-10	-7	-11	-5	-23	-22	-26
Interest Expense	0	-	0	-	2	0	5	0	-	-
Depreciation	-	-	1	1	1	1	1	1	1	1
Income Before Tax	-7	-12	-10	-6	-10	-12	-8	-25	-20	-27
Income Tax Expense	1	2	0	0	0	0	0	0	0	0
Net Income	-5	-8	-8	-4	-7	-8	-6	-17	-13	-17
Net Profit Margin	-8020.89%	-296.29%	-121.42%	-46071.10%	-656230.03%	-1175023.56%	-55.47%	-98591260.00%	-3687419.82%	-1160.23%

Kazia Therapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Sep 2024
Net Income	-5	-6	-11	-13	-3	-3	-6	-8	-17
Operating Cash Flow	-5	-4	-11	-8	-3	-3	-6	-6	-3
Investing Cash Flow	0	0	0	7	-	-	-5	5	-
Financing Cash Flow	1	2	3	5	3	3	7	4	1
Change in Cash	-3	-1	-19	4	0	0	-3	3	-3

Kazia Therapeutics Ltd Annual Cash Flow

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Net Income	-12	-10	-6	-10	-12	-8	-24	-20	-26
Operating Cash Flow	-11	-11	-8	-6	-8	-9	-22	-15	-9
Investing Cash Flow	0	-7	0	2	-2	-2	-2	-	-
Financing Cash Flow	0	0	3	3	12	28	3	12	5
Change in Cash	-10	-18	-8	0	3	18	-20	-2	-3

Global Institutional Holdings in Kazia Therapeutics Ltd

Funds	Holdings
Rhumbline Advisers	0.03%
GAMMA Investing LLC	0.02%
Advisor Group Holdings, Inc.	0%
SIMPLEX TRADING, LLC	0%
Citigroup Inc	0%

See all

Insights on Kazia Therapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 5.0 → 2.48M (in $), with an average increase of 100.0% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 200.3%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 118.3%
NEGATIVE IMPACT
Price Dip
In the last 3 years, KZIA stock has moved down by -88.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -3.43M → -17.95M (in $), with an average decrease of 77.3% per quarter

About Kazia Therapeutics Ltd

innovative. focused. agile. kazia therapeutics is an agile, oncology-focused biotechnology company, based in sydney, australia. we have two clinical staged drug development candidates and an early stage discovery program, across a range of oncology indications. our lead program is gdc-0084, a small molecule inhibitor of the pi3k / akt / mtor pathway, which is being developed to treat glioblastoma multiforme, the primary and most aggressive form of brain cancer. licensed from genentech in late 2016, gdc-0084 is anticipated to enter phase ii clinical trials in 2017. trxe-002-1, or cantrixil is kazia’s second drug development candidate under development as a treatment for ovarian cancer. the chemotherapeutic is currently undergoing a phase 1 clinical trial in hospitals across australia and the united states. initial data on this trial is expected to be reported early in 2018. kazia therapeutics is trading under the following tickers: asx: kza nasdaq: kzia for more information, please visi

Organisation	Kazia Therapeutics Ltd
Headquarters	Three International Towers, Sydney, NSW, Australia, 2000
Industry	Health Technology
CEO	Dr. John Edwin Friend II, M.D.
E-voting on shares	Click here to vote

Key Management of Kazia Therapeutics Ltd

Name	Title
Dr. John Edwin Friend II, M.D.	Chief Executive Officer & MD
Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC	Company Secretary
Mr. Jeffrey Bonacorda	VP of Finance & Controller

FAQs

What is Kazia Therapeutics Ltd share price today?

Kazia Therapeutics Ltd share price today is $8.08 as on September 17, 2025 at 12:48 am IST at the close of the market. Kazia Therapeutics Ltd share today touched a day high of $8.28 and a low of $7.78.

What is the 52 week high and 52 week low for Kazia Therapeutics Ltd share?

Kazia Therapeutics Ltd share touched a 52 week high of $39.05 on November 4, 2024 and a 52 week low of $2.86 on April 17, 2025. Kazia Therapeutics Ltd stock price today i.e. September 17, 2025 at 12:48 am IST is closed at $8.08,which is 79.31% down from its 52 week high and 182.52% up from its 52 week low.

What is Kazia Therapeutics Ltd's market capitalisation today?

Kazia Therapeutics Ltd market capitalisation is $0.00T as on September 17, 2025 at 12:48 am IST.

How to invest in Kazia Therapeutics Ltd Stock (KZIA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kazia Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kazia Therapeutics Ltd Shares that will get you 0.1856 shares as per Kazia Therapeutics Ltd share price of $8.08 per share as on September 17, 2025 at 12:48 am IST.

What is the minimum amount required to buy Kazia Therapeutics Ltd Stock (KZIA) from India?

Indian investors can start investing in Kazia Therapeutics Ltd (KZIA) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 1:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Kazia Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 1:39 pm IST). Based on Kazia Therapeutics Ltd share’s latest price of $8.08 as on September 17, 2025 at 12:48 am IST, you will get 1.2376 shares of Kazia Therapeutics Ltd. Learn more about fractional shares .

What are the returns that Kazia Therapeutics Ltd has given to Indian investors in the last 5 years?

Kazia Therapeutics Ltd stock has given -97.68% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?